4Filing Date: Sep 10, 2026

Agilent Technologies

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001090872-26-000067
Total Value$120.0K
Trades2
Insiders1

Transaction Details

Boehnlein Glenn S
Director·Direct
Grant · Acquire
Common Stock
Shares+817
Price$146.85
Total Value$120.0K
Shares Owned After817
Transaction DateSep 8, 2026
Footnotes ▸

Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant.

Boehnlein Glenn S
Director·Indirect · Boehnlein 2017 Trust
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After35
Footnotes ▸

Shares held by the Boehnlein 2017 Trust for which Glenn and Susan Boehnlein are the trustees.

Post-Transaction Holdings

Boehnlein Glenn S · Director
SecuritySharesChange
Common Stock852+817 (2334.29%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-09-08 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: AGILENT TECHNOLOGIES, INC. (A) CIK: 0001090872 --- Reporting Owner --- Name: Boehnlein Glenn S CIK: 0001670936 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-09-08 | Code: A (Grant or award) Shares: +817 | Price: $146.85 Total Value: $119,976.45 Shares Owned After: 817 | Ownership: D (Direct) Footnotes: [F1] Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. --- Holdings --- [Holding #1] Security: Common Stock Ownership: I (Indirect) Footnotes: [F2] Shares held by the Boehnlein 2017 Trust for which Glenn and Susan Boehnlein are the trustees. --- Footnotes (Complete Index) --- F1: Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. F2: Shares held by the Boehnlein 2017 Trust for which Glenn and Susan Boehnlein are the trustees. --- Signature --- /s/ /s/ Shirley Qin, attorney-in-fact for Mr. Boehnlein (2026-09-10)

keid analysis is for reference only and does not constitute investment advice.